Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • The problem of bacterial group behavior in medicine
  • Beyond the small talk: quorum sensing controls virulence
  • The biofilm problem
  • Conclusions
  • Acknowledgments
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article (85)

Advertisement

Perspective Series Free access | 10.1172/JCI20099

Bacterial communication and group behavior

E. Peter Greenberg

Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA

Address correspondence to: E. Peter Greenberg, 540 Eckstein Medical Research Building, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. Phone: (319) 335-7775; Fax: (319) 335-7949; E-mail: Everett-greenberg@uiowa.edu.

Find articles by Greenberg, E. in: JCI | PubMed | Google Scholar

Published November 1, 2003 - More info

Published in Volume 112, Issue 9 on November 1, 2003
J Clin Invest. 2003;112(9):1288–1290. https://doi.org/10.1172/JCI20099.
© 2003 The American Society for Clinical Investigation
Published November 1, 2003 - Version history
View PDF
Abstract

The existence of species-specific and interspecies bacterial cell-cell communication and group organization was only recently accepted. Researchers are now realizing that the ability of these microbial teams to communicate and form structures, known as biofilms, at key times during the establishment of infection significantly increases their ability to evade both host defenses and antibiotics. This Perspective series discusses the known signaling mechanisms, the roles they play in both chronic Gram-positive and Gram-negative infections, and promising therapeutic avenues of investigation.

The past decade has seen the emergence of a new field in basic microbiology. The new basic knowledge has led to interest and activity in developing therapeutic agents to treat certain kinds of persistent bacterial infections. Scientists had long held the view that bacterial cells behaved as self-sufficient individuals, unable to organize themselves into groups or communicate. During infection, the bacterial mass was considered nothing more than the sum of these individuals. I have called this the lone-wolf view of a bacterial cell (1). The idea that bacteria could function as groups and that individuals within the group could respond to the group as a whole seemed almost ludicrous. This sort of peer pressure was thought to be restricted to “higher organisms,” like humans. Through hard work and creativity, a small band of microbiologists chipped away at this viewpoint, and now it is generally accepted that bacteria produce, and respond as groups to, chemical signals and that this interaction can lead to the coordination of group bacterial activities. This phenomenon has become known as quorum sensing (2–4). We also understand that groups of bacteria can form physical structures with unique characteristics, so-called biofilms (5, 6). Quorum sensing and biofilm biology have become very active areas in microbiology, and a large group of investigators is working on these fascinating aspects of bacterial biology, hoping to develop new therapeutic agents to treat associated persistent bacterial infections.

The problem of bacterial group behavior in medicine

Of particular relevance to this Perspective series, we now understand that the ability of bacteria to function as groups is crucial in the development of a number of infectious diseases (6). In fact, biofilms cause a variety of persistent infections, including chronic middle ear infections, bone infections, heart valve infections, infections related to implanted medical devices, and lung infections in people with the autosomal recessive inherited disease cystic fibrosis (6). A recent report also indicated that the chronic nature of some urinary tract infections is related to the ability of the infectious agent Escherichia coli to form a biofilm (7). The armament of therapeutic agents available to treat bacterial infections today is restricted to antibiotics developed specifically to kill or stop the growth of individual bacteria. The development of these agents did not take into account the unique biology of bacterial groups. This is a problem for a number of reasons, not the least of which is that when bacteria are growing within a biofilm they lose their sensitivity to antibiotics. Thus biofilms result in persistent infections that cannot be resolved with standard antibiotic treatments (6). Because we have not considered the problem of group biology in bacteria until recently, good therapeutic strategies to treat biofilm infection are not available. One might imagine that bacterial communication systems represent an Achilles’ heel, a fragile target for potential new anti-infective drugs. This idea has not escaped the notice of both academic investigators and scientists in the biotechnology industry. The reviews in this Perspective series will cover many interesting aspects of our basic knowledge about the diversity of quorum sensing systems and the relevance of these systems to bacterial diseases. Several of the reviews will also address issues surrounding the targeting of bacterial group behavior as a therapeutic approach for the treatment of certain persistent infections.

Beyond the small talk: quorum sensing controls virulence

The idea that bacteria can make species-specific extracellular chemicals, which signal the development of important traits, can be traced back to the 1960s (8, 9). Certain species of marine bacteria were shown to luminesce only when cultures reached sufficient cell density. The delay in luminescence in early culture growth was correlated to the bacterial production of an extracellular signal, later shown to be an acyl-homoserine lactone (10).

A pneumococcal phenomenon termed “natural competence” was also the subject of considerable scrutiny. This ability of the pneumococcus to take up DNA occurs in the late logarithmic stage of culture growth when cell density is high. DNA uptake has been shown to be dependent on the “competence factor,” an extracellular signaling molecule that accumulates in the growth medium at high cell density (9). We now know that the competence factor is a peptide signal (11). These first prescient reports (8, 9) were, at best, ignored by most microbiologists. Subsequent identification of the chemical nature of these bacterial signals and identification of the signal receptors gradually led to acceptance of the idea that communication among bacterial cells was possible. Yet most researchers considered bacterial communication to be isolated to only a few specific bacterial strains or species, and not important to bacterial virulence. Approximately 15 years ago, several independent studies reported that acyl-homoserine lactone–mediated signaling was not restricted to luminescent bacteria. Several different Gram-negative bacterial species were shown to make acyl-homoserine lactones (12), and genes encoding homologs of the acyl-homoserine lactone receptor were identified in plant and human pathogens (13, 14). In this Perspective series, Roger Smith and Barbara Iglewski discuss acyl-homoserine lactone signaling in the opportunistic pathogen Pseudomonas aeruginosa (15). Morten Hentzer and Michael Givskov discuss some of the known signaling mechanisms and potential antipathogenic drugs that specifically target these systems in a manner unlikely to pose a selective pressure for the development of resistant mutants — an increasing consequence of antibiotic treatment (16). One promising approach includes the production of synthetic agents that mimic endogenous anti–quorum sensing compounds produced by certain algae that successfully inhibit bacterial surface colonization.

Unlike Gram-negative bacteria, which use acyl-homoserine lactone signals, pneumococcal quorum sensing circuits use a small peptide signal, and we now understand that Gram-positive bacteria commonly use peptide signals in communication. Examples of these peptide-based signaling systems in pathogenic bacteria will be described by Dennis Cvitkvitch and colleagues in their review of Streptococcus quorum sensing (17), and by Jeremy Yarwood and Patrick Schlievert in their review of the control of virulence by quorum sensing in Staphylococcus (18).

A theme that will emerge from this series of reviews is that quorum sensing often controls genes involved in virulence. Quorum sensing allows a bacterial pathogen to coordinate the synthesis of extracellular virulence factors so that they are not expressed early in infection when the bacterial load is low. One can use a military analogy: the bacterial army does not display its weapons until the troops have amassed and are prepared to attack the host.

Now that it is generally accepted that bacteria can communicate and function as groups, new types of so-called quorum sensing systems are being described frequently. One particularly interesting example is the Autoinducer-2 system described in the Perspective by Michael Federle and Bonnie Bassler (19). In 1979, we reported that one particular marine luminescent baterial species could respond to signal molecules produced by other marine bacteria by activation of its luminescence genes. We called this nonspecific signaling “alloinduction” (20) and pursued it no further. Bassler and her colleagues have further investigated this signal and receptor and have recognized the implications of this phenomenon. They and others have shown that many different bacteria can sense and respond to this signal, and that this signaling mechanism also governs the expression of specific virulence factors. In their series Perspective, Federle and Bassler discuss their view that many bacteria use this common signal to monitor the general level of the surrounding microbial population and activity and that making a general measurement may afford some advantage to the group as a whole. As an aside, we have placed the review by Federle and Bassler first in this series because it provides a general overview of the mechanisms of several specific signaling systems as a way to introduce the non–species specific system on which they focus their work. So this review serves to introduce the reviews that follow.

The biofilm problem

Many of the Perspectives in this series on quorum sensing will touch on the subject of biofilms. Microbiologists have become increasingly interested in biofilms and their importance in medicine. Biofilms are groups of bacteria encased in a self-produced extracellular polymeric matrix. Modern imaging technology has revealed that biofilms are organized into heterogeneous groups of individual organisms. Even when the biofilm consists of a single bacterial species, elaborate structures are formed and bacteria within specific regions of the biofilm exhibit different activities when compared with bacteria in other regions (Figure 1). I have already discussed several examples of biofilm-based infections and some of the reasons why biofilms cause persistent infections not readily resolved by antibiotic treatment.

An example of differentiated structures in a single-species biofilm. ScanniFigure 1

An example of differentiated structures in a single-species biofilm. Scanning confocal microscope image of a P. aeruginosa biofilm growing under a flow on a glass surface. The large (about 100 μm in height) differentiated mushroom-like structures are labeled with the green fluorescent protein expressed from a promoter controlled by quorum sensing and the red fluorescent protein expressed from a constitutively active promoter. The quorum-controlled product is found mostly in the base of the structures. Image provided by Yannick Lequette, University of Iowa.

Investigators working on biofilms and those working on quorum sensing have a common interest in how bacteria function as a group. Our finding that, in certain bacterial species, quorum sensing can control how biofilms develop has served as a catalyst to bring the two fields of research together. A connection between quorum sensing and biofilm-pattern development in several bacterial species has been demonstrated. In some bacteria, including P. aeruginosa and the emerging pathogen Burkholderia cepacia, quorum sensing seems to play a role in the development of normal biofilm structures (21–23). In other bacteria, quorum sensing may play a role in the dispersal of individual organisms from the biofilm. This appears to be the case for the photosynthetic bacterium Rhodobacter sphaeroides (23). Although the connection between quorum sensing and biofilm development might entice one to think that biofilm infections can be controlled by interference with quorum sensing, this has yet to be established. Organisms like P. aeruginosa are still able to form biofilms, albeit abnormal ones, without quorum sensing. Hentzer and Givskov (16) discuss recent studies suggesting that quorum sensing might be a suitable target for anti-Pseudomonas biofilm therapy.

The quorum sensing–biofilm connection helped to establish that there is a genetic component to biofilm development. This, and a direct classical genetic-screening approach (24), have introduced new ways in which to study biofilm biology. The link between quorum sensing and biofilm development has brought together a large group of biologists interested in bacterial group dynamics. Later in this Perspective series, William Costerton and colleagues discuss the special biology of biofilms (25). Bacteria residing within biofilms can resist host defenses, and they also demonstrate a tolerance to antibiotics at concentrations that would kill them outside of the biofilm environment. The coalescence of scientists interested in bacterial group behavior into a common research field represents a potentially powerful force in the development of suitable therapeutics for cystic fibrosis lung infections and other biofilm-related diseases.

Conclusions

As with any new area in science, there is a risk of being naive in our enthusiasm. This emerging area in bacterial pathogenesis, communities, and cell-to-cell communication will benefit from the input of population biologists and ecologists, scientists who traditionally have not been deeply involved in research on infections. It has become clear that the special behavior of microbial groups can influence disease processes. We now need to investigate what selective pressures drive group behavior and to develop drugs designed to modulate bacterial group behavior, as opposed to bacteriocidal therapies. In developing these therapies for clinical application, we must overcome many hurdles. How would a clinical trial be designed? What sort of infections should be targeted as we gain the technical expertise to control bacterial group activities in a clinical setting? This Perspective series will address these challenges and others in the emerging field of bacterial communication and group behavior.

Acknowledgments

I am grateful to John Ashkenas and Brooke Urquhart Grindlinger for all of their efforts in the development and production of this Perspective series.

Footnotes

Conflict of interest: The author has declared that no conflict of interest exists.

References
  1. Greenberg, EP. Bacterial communication: tiny teamwork. Nature. 2003. 424:134.
    View this article via: PubMed CrossRef Google Scholar
  2. Fuqua, WC, Winans, SC, Greenberg, EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 1994. 176:269-275.
    View this article via: PubMed Google Scholar
  3. Fuqua, C, Parsek, MR, Greenberg, EP. Regulation of gene expression by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu. Rev. Genet. 2001. 35:439-468.
    View this article via: PubMed CrossRef Google Scholar
  4. Whitehead, NA, Barnard, AML, Slater, H, Simpson, NJL, Salmond, GPC. Quorum sensing in gram-negative bacteria. FEMS Microbiol. Rev. 2001. 25:365-404.
    View this article via: PubMed CrossRef Google Scholar
  5. Costerton, JW, Lewandowski, Z, Caldwell, DE, Korber, DR, Lappin-Scott, HM. Microbial biofilms. Annu. Rev. Microbiol. 1995. 49:711-745.
    View this article via: PubMed CrossRef Google Scholar
  6. Costerton, JW, Stewart, PS, Greenberg, EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999. 284:1318-1322.
    View this article via: PubMed CrossRef Google Scholar
  7. Anderson, GG, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003. 301:105-107.
    View this article via: PubMed CrossRef Google Scholar
  8. Nealson, KH, Platt, T, Hastings, JW. Cellular control of the synthesis and activity of the bacterial luminescent system. J. Bacteriol. 1970. 104:313-322.
    View this article via: PubMed Google Scholar
  9. Tomasz, A. Control of the competent state in Pneumococcus by a hormone-like cell product: and example for a new type of regulatory mechanism in bacteria. Nature. 1964. 208:155-159.
  10. Eberhard, A, et al. Structural identification of autoinducer of Photobacterium fischeri luciferase. Biochemistry. 1981. 20:2444-2449.
    View this article via: PubMed CrossRef Google Scholar
  11. Haverstein, LS, Coomaraswamy, G, Morrison, DA. An unmodified heptadecapeptide pheromone induced competence for genetic transformation in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 1995. 92:11140-11144.
    View this article via: PubMed CrossRef Google Scholar
  12. Bainton, NJ, et al. A general role for the lux autoinducer in bacterial cell signalling: control of antibiotic biosynthesis in Erwinia. Gene. 1992. 116:87-91.
    View this article via: PubMed CrossRef Google Scholar
  13. Gambello, MJ, Iglewski, BH. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J. Bacteriol. 1991. 173:3000-3009.
    View this article via: PubMed Google Scholar
  14. Zhang, L, Murphy, PJ, Kerr, A, Tate, ME. Agrobacterium conjugation and gene regulation by N-acyl-homoserine lactones. Nature. 1993. 362:446-448.
    View this article via: PubMed CrossRef Google Scholar
  15. Smith, R.S., and Iglewski, B.H. 2003. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J. Clin. Invest. In press.
  16. Hentzer, M, Givskov, M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest. 2003. 112:1300-1307. doi:10.1172/JCI200320074.
    View this article via: JCI PubMed Google Scholar
  17. Cvitkovitch, D.G., Li, Y.-H., and Ellen, R.P. 2003. Quorum sensing and biofilm formation in Streptococcal infections. J. Clin. Invest. In press.
  18. Yarwood, J.M., and Schlievert, P.M. 2003. Quorum sensing in Staphylococcus infections. J. Clin. Invest. In press.
  19. Federle, MJ, Bassler, BL. Interspecies communication in bacteria. J. Clin. Invest. 2003. 112:1291-1299. doi:10.1172/JCI200320195.
    View this article via: JCI PubMed Google Scholar
  20. Greenberg, EP, Ulitzur, S, Hastings, JW. Induction of luciferase synthesis in Beneckea harveyi. Arch. Microbiol. 1979. 120:87-91.
    View this article via: CrossRef Google Scholar
  21. Davies, DG, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998. 280:295-298.
    View this article via: PubMed CrossRef Google Scholar
  22. Huber, B, et al. The cep quorum-sensing system of Burkholderia cepacia H111. Microbiolgy. 2001. 147:2517-2528.
  23. Puskas, A, Greenberg, EP, Kaplan, S, Schaefer, AL. A quorum-sensing system in the free-living photosynthetic bacterium Rhodobacter sphaeroides. J. Bacteriol. 1997. 179:7530-7537.
    View this article via: PubMed Google Scholar
  24. O’Toole, GA, Kolter, R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 1998. 28:449-461.
    View this article via: PubMed CrossRef Google Scholar
  25. Costerton, W., et al. 2003. The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Invest. In press.
Version history
  • Version 1 (November 1, 2003): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Review Series

Quorum sensing

  • Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections
    Morten Hentzer et al.
  • Bacterial communication and group behavior
    E. Peter Greenberg
  • Interspecies communication in bacteria
    Michael J. Federle et al.
  • Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target
    Roger S. Smith et al.
  • The application of biofilm science to the study and control of chronic bacterial infections
    William Costerton et al.
  • Quorum sensing and biofilm formation in Streptococcal infections
    Dennis G. Cvitkovitch et al.
  • Quorum sensing in Staphylococcus infections
    Jeremy M. Yarwood et al.

Metrics

  • Article usage
  • Citations to this article (85)

Go to

  • Top
  • Abstract
  • The problem of bacterial group behavior in medicine
  • Beyond the small talk: quorum sensing controls virulence
  • The biofilm problem
  • Conclusions
  • Acknowledgments
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts